The global Paclitaxel Injection market was valued at $2200 million in 2017, and MAResearch analysts predict the global market size will reach $4960 million by the end of 2028, growing at a CAGR of 7.67% between 2017 and 2028.
This report provides detailed historical analysis of global market for Paclitaxel Injection from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Paclitaxel Injection market.
Leading players of Paclitaxel Injection including:
- Bristol-Myers Squibb
- Celgene Corporation
- Hospira
- Biological E.
- Taj Accura
- Khandelwal Laboratories
- Luye Pharma
- Beijing Youcare
- Beijing Union
- Haiyao
- Chuntch
- Teva
- Sandoz
- Accord
- Mylan Inc.
- Medac GmbH
- Actavis
- Fresenius Kabi
Market split by Type, can be divided into:
- 5ml, 30mg
- 10ml, 60mg
- 16.7ml, 100mg
- 25ml, 150mg
- 50ml, 300mg
Market split by Application, can be divided into:
- Ovarian cancer
- Breast cancer
- Cervical cancer
- Pancreatic cancer
Market split by Sales Channel, can be divided into:
- Direct Sales
- Distribution Sales
Market segment by Region/Country including:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America Brazil, Argentina, Colombia and Chile etc.)
- Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
Table of content
Chapter 1 Paclitaxel Injection Market Overview
1.1 Paclitaxel Injection Definition
1.2 Global Paclitaxel Injection Market Size Status and Outlook (2013-2028)
1.3 Global Paclitaxel Injection Market Size Comparison by Region (2013-2028)
1.4 Global Paclitaxel Injection Market Size Comparison by Type (2013-2028)
1.5 Global Paclitaxel Injection Market Size Comparison by Application (2013-2028)
1.6 Global Paclitaxel Injection Market Size Comparison by Sales Channel (2013-2028)
1.7 Paclitaxel Injection Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Paclitaxel Injection Market Segment Analysis by Player
2.1 Global Paclitaxel Injection Sales and Market Share by Player (2016-2018)
2.2 Global Paclitaxel Injection Revenue and Market Share by Player (2016-2018)
2.3 Global Paclitaxel Injection Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Paclitaxel Injection Market Segment Analysis by Type
3.1 Global Paclitaxel Injection Market by Type
3.1.1 5ml, 30mg
3.1.2 10ml, 60mg
3.1.3 16.7ml, 100mg
3.1.4 25ml, 150mg
3.1.5 50ml, 300mg
3.2 Global Paclitaxel Injection Sales and Market Share by Type (2013-2018)
3.3 Global Paclitaxel Injection Revenue and Market Share by Type (2013-2018)
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: help@24marketreports.com
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports